MedTrace Logo

Cross Therapy Registry - Oedema - EU (CTR-Oedema-EU)

NCT04704557 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2025-12-04

No results posted yet for this study

Summary

The geko™ Cross Therapy Registry - Oedema - EU (gekoTM CTR - Oedema- EU) study will prospectively and systematically collect clinical data on all device variants used in standard care pathways for edema management allowing for the monitoring of patient outcomes during a follow-up period of up to twelve months.

Conditions

  • Edema Leg

Interventions

DEVICE

geko Neuromuscular Electro Stimulator (NMES)

Neuromuscular Electro Stimulator (NMES)

Sponsors & Collaborators

  • Firstkind Ltd

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-21
Primary Completion
2021-11-30
Completion
2021-11-30

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04704557 on ClinicalTrials.gov